257 related articles for article (PubMed ID: 31895687)
1. Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis.
Guo Q; Jing FJ; Xu W; Li X; Li X; Sun JL; Xing XM; Zhou CK; Jing FB
Aging (Albany NY); 2019 Dec; 12(1):80-105. PubMed ID: 31895687
[TBL] [Abstract][Full Text] [Related]
2. CD13 downregulation mediated by ubenimex inhibits autophagy to overcome 5-FU resistance by disturbing the EMP3/FAK/NF-κB pathway in gastric cancer cells.
Xiu T; Guo Q; Jing F; Shi Y; Jing F
Transl Cancer Res; 2022 Aug; 11(8):2487-2500. PubMed ID: 36093528
[TBL] [Abstract][Full Text] [Related]
3. Ubenimex Reverses MDR in Gastric Cancer Cells by Activating Caspase-3-Mediated Apoptosis and Suppressing the Expression of Membrane Transport Proteins.
Guo Q; Jing FJ; Qu HJ; Xu W; Han B; Xing XM; Ji HY; Jing FB
Biomed Res Int; 2019; 2019():4390839. PubMed ID: 30915355
[TBL] [Abstract][Full Text] [Related]
4. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT.
Tan J; You Y; Xu T; Yu P; Wu D; Deng H; Zhang Y; Bie P
Toxicol Lett; 2014 Jan; 224(1):7-15. PubMed ID: 24144893
[TBL] [Abstract][Full Text] [Related]
5. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
[TBL] [Abstract][Full Text] [Related]
6. A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma.
Yamashita M; Wada H; Eguchi H; Ogawa H; Yamada D; Noda T; Asaoka T; Kawamoto K; Gotoh K; Umeshita K; Doki Y; Mori M
Int J Oncol; 2016 Jul; 49(1):89-98. PubMed ID: 27121124
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.
Li B; Wang W; Li Z; Chen Z; Zhi X; Xu J; Li Q; Wang L; Huang X; Wang L; Wei S; Sun G; Zhang X; He Z; Zhang L; Zhang D; Xu H; El-Rifai W; Xu Z
Cancer Lett; 2017 Dec; 410():212-227. PubMed ID: 28965855
[TBL] [Abstract][Full Text] [Related]
8. Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
Tsukamoto H; Shibata K; Kajiyama H; Terauchi M; Nawa A; Kikkawa F
BMC Cancer; 2008 Mar; 8():74. PubMed ID: 18366676
[TBL] [Abstract][Full Text] [Related]
9. Salinomycin reduces epithelial-mesenchymal transition-mediated multidrug resistance by modifying long noncoding RNA HOTTIP expression in gastric cancer cells.
Mao Z; Wu Y; Zhou J; Xing C
Anticancer Drugs; 2019 Oct; 30(9):892-899. PubMed ID: 30882398
[TBL] [Abstract][Full Text] [Related]
10. Apoptin-derived peptide reverses cisplatin resistance in gastric cancer through the PI3K-AKT signaling pathway.
Zhou D; Liu W; Liang S; Sun B; Liu A; Cui Z; Han X; Yuan L
Cancer Med; 2018 Apr; 7(4):1369-1383. PubMed ID: 29522284
[TBL] [Abstract][Full Text] [Related]
11. Ubenimex, an APN inhibitor, could serve as an anti‑tumor drug in RT112 and 5637 cells by operating in an Akt‑associated manner.
Wang X; Liu Y; Liu W; Zhang Y; Guo F; Zhang L; Cui M; Liu S; Wu R
Mol Med Rep; 2018 Mar; 17(3):4531-4539. PubMed ID: 29328441
[TBL] [Abstract][Full Text] [Related]
12. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
Zhou J; Chen Q
FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
[TBL] [Abstract][Full Text] [Related]
13. Ubenimex suppresses glycolysis mediated by CD13/Hedgehog signaling to enhance the effect of cisplatin in liver cancer.
Shi Y; Guo Q; Jing F; Shang X; Zhou C; Jing F
Transl Cancer Res; 2023 Oct; 12(10):2823-2836. PubMed ID: 37969369
[TBL] [Abstract][Full Text] [Related]
14. Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway.
Chen D; Lin X; Zhang C; Liu Z; Chen Z; Li Z; Wang J; Li B; Hu Y; Dong B; Shen L; Ji J; Gao J; Zhang X
Cell Death Dis; 2018 Jan; 9(2):123. PubMed ID: 29374144
[TBL] [Abstract][Full Text] [Related]
15. Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism.
Liu S; Gao M; Wang X; Ding S; Lv J; Gao D; Wang Z; Niu Z
Oncotarget; 2016 Nov; 7(48):79141-79153. PubMed ID: 27816967
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of MGMT-mediated autophagy suppression decreases cisplatin chemosensitivity in gastric cancer.
Lei Y; Tang L; Hu J; Wang S; Liu Y; Yang M; Zhang J; Tang B
Biomed Pharmacother; 2020 May; 125():109896. PubMed ID: 32007918
[TBL] [Abstract][Full Text] [Related]
17. CD13 Induces Autophagy to Promote Hepatocellular Carcinoma Cell Chemoresistance Through the P38/Hsp27/CREB/ATG7 Pathway.
Zhao Y; Wu H; Xing X; Ma Y; Ji S; Xu X; Zhao X; Wang S; Jiang W; Fang C; Zhang L; Yan F; Wang X
J Pharmacol Exp Ther; 2020 Sep; 374(3):512-520. PubMed ID: 32571958
[TBL] [Abstract][Full Text] [Related]
18. The effects and mechanism of α-mangostin on chemosensitivity of gastric cancer cells.
Li RR; Zeng DY
Kaohsiung J Med Sci; 2021 Aug; 37(8):709-717. PubMed ID: 34003591
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
[TBL] [Abstract][Full Text] [Related]
20. Ubenimex enhances Brd4 inhibition by suppressing HEXIM1 autophagic degradation and suppressing the Akt pathway in glioma cells.
Han L; Zhao Q; Liang X; Wang X; Zhang Z; Ma Z; Zhao M; Wang A; Liu S
Oncotarget; 2017 Jul; 8(28):45643-45655. PubMed ID: 28484091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
